CIK 0001829802
- Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-10 | Cambrian BioPharma Inc 10% owner | Purchase | +10,000 | $5.28 | $53K | 4,929,413 |
| 2021-12-30 | Peyer James Director | Purchase | +1,127 | $4.85 | $5K | 4,919,413 |
| 2021-12-30 | Cambrian BioPharma Inc 10% owner | Purchase | +1,127 | $4.85 | $5K | 4,919,413 |
| 2021-12-29 | Peyer James Director | Purchase | +69,000 | $4.98 | $344K | 4,918,286 |
| 2021-12-29 | Cambrian BioPharma Inc 10% owner | Purchase | +69,000 | $4.98 | $344K | 4,918,286 |
| 2021-12-28 | Peyer James Director | Purchase | +11,288 | $5.28 | $60K | 4,849,286 |
| 2021-12-28 | Cambrian BioPharma Inc 10% owner | Purchase | +11,288 | $5.28 | $60K | 4,849,286 |
| 2021-12-27 | Peyer James Director | Purchase | +3,712 | $5.30 | $20K | 4,837,998 |
| 2021-12-27 | Cambrian BioPharma Inc 10% owner | Purchase | +3,712 | $5.30 | $20K | 4,837,998 |
| 2021-12-23 | Peyer James Director | Purchase | +11,000 | $5.27 | $58K | 4,834,286 |
| 2021-12-23 | Cambrian BioPharma Inc 10% owner | Purchase | +11,000 | $5.27 | $58K | 4,834,286 |
| 2021-12-17 | Peyer James Director | Purchase | +117 | $5.29 | $619 | 4,823,286 |
| 2021-12-17 | Cambrian BioPharma Inc 10% owner | Purchase | +117 | $5.29 | $619 | 4,823,286 |
| 2021-12-16 | Cambrian BioPharma Inc 10% owner | Purchase | +10,925 | $5.25 | $57K | 4,823,169 |
| 2021-12-16 | Peyer James Director | Purchase | +10,925 | $5.25 | $57K | 4,823,169 |
| 2021-12-10 | RICKS THOMAS G Director | Purchase | +20,000 | $5.86 | $117K | 341,769 |
| 2021-12-09 | RICKS THOMAS G Director | Purchase | +20,000 | $6.62 | $132K | 321,769 |
| 2021-08-11 | Pierce Robert Hamilton Chief Scientific Officer | Sale | −16,030 | $7.34 | $118K | 0 |
| 2021-08-10 | Pierce Robert Hamilton Chief Scientific Officer | Sale | −66,350 | $7.13 | $473K | 16,030 |
| 2021-08-09 | Pierce Robert Hamilton Chief Scientific Officer | Sale | −6,982 | $7.06 | $49K | 82,380 |
Page 16 of 20 · 385 trades